Sitting on a Cash Pile 9.0? This Ultra-Rare Gene Therapy Pharma Company Inks Key Deal

Sitting on a Cash Pile 9.0? This Ultra-Rare Gene Therapy  Pharma Company Inks Key Deal

#cash #Bullish #Buy $RARE Ultragenyx Pharmaceuticals Inc’s (NASDAQ:RARE) breakout on 5 October at 89.25 was confirmed Thursday, 24 December at 172.87. There no resistance, the Key support at 102.59, our target price into Y 2021 is 200+. And our overall technical analysis is Very Bullish, thus Monday’s HeffX-LTN buy rating. News, click here. Ultragenyx Pharmaceutical […]